Avicella Capital is a venture capital firm that invests in innovative healthcare assets, including therapeutics, medical devices, diagnostics, and health‑tech companies. The firm focuses on funding projects with proven concepts and transformative potential to improve patient outcomes and accelerate treatment access. Its executive team spans North America and Europe, drawing on deep scientific, clinical, and financial expertise.
No recent news for this company.